Viewing Study NCT00588666


Ignite Creation Date: 2025-12-24 @ 4:19 PM
Ignite Modification Date: 2026-01-29 @ 7:37 PM
Study NCT ID: NCT00588666
Status: COMPLETED
Last Update Posted: 2016-01-22
First Post: 2007-12-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma
Sponsor:
Organization: